Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

921 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Recipient PTPN22 -1123 C/C genotype predicts acute graft-versus-host disease after HLA fully matched unrelated bone marrow transplantation for hematologic malignancies.
Espinoza JL, Takami A, Onizuka M, Morishima Y, Fukuda T, Kodera Y, Akiyama H, Miyamura K, Mori T, Nakao S; Japan Marrow Donor Program. Espinoza JL, et al. Among authors: morishima y. Biol Blood Marrow Transplant. 2013 Feb;19(2):240-6. doi: 10.1016/j.bbmt.2012.09.014. Epub 2012 Sep 28. Biol Blood Marrow Transplant. 2013. PMID: 23025987 Free article.
Clinical relevance of a newly identified HLA-A24-restricted minor histocompatibility antigen epitope derived from BCL2A1, ACC-1, in patients receiving HLA genotypically matched unrelated bone marrow transplant.
Nishida T, Akatsuka Y, Morishima Y, Hamajima N, Tsujimura K, Kuzushima K, Kodera Y, Takahashi T. Nishida T, et al. Among authors: morishima y. Br J Haematol. 2004 Mar;124(5):629-35. doi: 10.1111/j.1365-2141.2004.04823.x. Br J Haematol. 2004. PMID: 14871250 Free article.
Effect of conditioning regimen on the outcome of bone marrow transplantation from an unrelated donor.
Kanda Y, Sakamaki H, Sao H, Okamoto S, Kodera Y, Tanosaki R, Kasai M, Hiraoka A, Takahashi S, Miyawaki S, Kawase T, Morishima Y, Kato S; Japan Marrow Donor Program. Kanda Y, et al. Among authors: morishima y. Biol Blood Marrow Transplant. 2005 Nov;11(11):881-9. doi: 10.1016/j.bbmt.2005.07.005. Biol Blood Marrow Transplant. 2005. PMID: 16275591 Free article.
Current status of hematopoietic cell transplantation for adult patients with hematologic diseases and solid tumors in Japan.
Imamura M, Asano S, Harada M, Ikeda Y, Kato K, Kato S, Kawa K, Kojima S, Morishima Y, Morishita Y, Nakahata T, Okamura J, Okamoto S, Shiobara S, Tanimoto M, Tsuchida M, Atsuta Y, Yamamoto K, Tanaka J, Hamajima N, Kodera Y. Imamura M, et al. Among authors: morishima y. Int J Hematol. 2006 Feb;83(2):164-78. doi: 10.1532/IJH97.05134. Int J Hematol. 2006. PMID: 16513537
KIR ligands and prediction of relapse after unrelated donor hematopoietic cell transplantation for hematologic malignancy.
Hsu KC, Gooley T, Malkki M, Pinto-Agnello C, Dupont B, Bignon JD, Bornhäuser M, Christiansen F, Gratwohl A, Morishima Y, Oudshoorn M, Ringden O, van Rood JJ, Petersdorf E; International Histocompatibility Working Group. Hsu KC, et al. Among authors: morishima y. Biol Blood Marrow Transplant. 2006 Aug;12(8):828-36. doi: 10.1016/j.bbmt.2006.04.008. Biol Blood Marrow Transplant. 2006. PMID: 16864053 Free article. Clinical Trial.
Allogeneic bone marrow transplantation from unrelated human T-cell leukemia virus-I-negative donors for adult T-cell leukemia/lymphoma: retrospective analysis of data from the Japan Marrow Donor Program.
Kato K, Kanda Y, Eto T, Muta T, Gondo H, Taniguchi S, Shibuya T, Utsunomiya A, Kawase T, Kato S, Morishima Y, Kodera Y, Harada M; Japan Marrow Donor Program. Kato K, et al. Among authors: morishima y. Biol Blood Marrow Transplant. 2007 Jan;13(1):90-9. doi: 10.1016/j.bbmt.2006.09.002. Biol Blood Marrow Transplant. 2007. PMID: 17222757 Free article.
921 results